Abilita Bio has established several global collaborations around the Enabled Membrane Proteins (EMP™) platform, including proof of concept agreements with three undisclosed top-15 pharmaceutical companies.
WORKING WITH ABILITA BIO
Abilita Bio is seeking corporate relationships under the following models:
Discovery-based licenses for single or multiple targets
Collaborative/risk-sharing development programs
To learn more about our collaboration models please contact us.